Headquartered in Geneva, Switzerland, Selexis SA is a global life science company with technologies for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins. The Company is dedicated to the development of innovative technologies and world-class expert services that significantly reduce the time, effort, and costs associated with developing high-performance mammalian cell lines for therapeutic protein production (e.g. monoclonal antibodies (MAbs), growth factors, enzymes). The Selexis SUREtechnology Platform™ is based on Selexis Genetic Elements™ — novel DNA-based elements that control the dynamic organization of chromatin within all mammalian cells and allow for higher and more stable expression of recombinant proteins. As of 4Q2011, Selexis has generated over 1,300 clonal cell lines being used in a variety of programs from discovery to late-stage clinical trials. The Company anticipates three products manufactured from cell lines using the Selexis SUREtechnology Platform™ to be launched in 2012. The technology platform includes:
- Selexis Genetic Elements™(SGE)
- Selexis SUREtech Vectors™
- Selexis SURE CHO-M Cell line™
- Selexis SURE CHO-M Genome™
- Selexis SUREfeed Strategy™
- Selexis SUREmedia™
- Selexis SUREfection Procedures™
- Selexis SUREHTSOptimization™
Selexis World-Class Drug Discovery and Development Services:
- Selexis SURE Cell line development™
- Selexis SUREclones™
- Selexis SUREvariant screening™
- Selexis SUREnatant™
- Selexis SUREpools™
YEAR FOUNDED
2001
FINANCIALS
Selexis SA is a privately held biotechnology company. Selexis SA has no securities registered under the United States Securities Act of 1933.
INDUSTRIES
- Bioproduction (biologics manufacturing)
- Biopharmaceuticals
- Biotechnology
- Cell line development for protein manufacturing
- Cell therapies
- Contract manufacturing
- Clinical research
- Diagnostics
- Pharmaceutical
- Vaccines
APPLICATIONS
- R&D
- Bioproduction
- Preclinical production
- Target discovery
- Cell based assays
- Diagnostics
CORPORATE HEADQUARTERS
Selexis SA
18 chemin des Aulx
1228 Plan-les-Ouates
Switzerland
Telephone: +41 (0)22 308 93 60
Fax: +41 (0)22 308 93 61
